A triple action CDK4/6-PI3K-BET inhibitor with augmented cancer cell cytotoxicity.
Adam M BurgoyneKendra R VannShweta JoshiGuillermo A MoralesFrancisco M VegaAlok SinghDhananjaya PalAran B MeratiTatiana G KutateladzeDonald L DurdenPublished in: Cell discovery (2020)